Grembecka, Jolanta
- University of Michigan · Pathology (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #4,763
- R01 Holder
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2011 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Pathology
NIH Funding · FY2023
Linked Award Amount
$1.7M
Full award amounts, FY2023
Award Records
3
Records listing this PI
Award-Linked Rank
#4,763
By linked amount among FY2023 PIs
Earliest Year Loaded
2011
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Grembecka, Jolanta as a PI. Multi-PI records show the full award amount for context.
- 1R01CA272561-01A1R01Contact PITargeting Menin in Acute Leukemia with Upregulated HOX GenesUniversity of Michigan · Pathology (NIH department code)$633.5Kaward amount
- 5R01CA244254-04R01Contact PIDevelopment of ASH1L inhibitors for acute leukemiaUniversity of Michigan · Pathology (NIH department code)$564Kaward amount
- 1R01CA276074-01R01Contact PIScreening for inhibitors of NSD3 as a treatment for lung cancerUniversity of Michigan · Pathology (NIH department code)$529.5Kaward amount
Award organization
Organizations that administered FY2023 awards listing Grembecka, Jolanta as a PI.
FY2023 award administered by University of Michigan (MI).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2011First NIH AwardUniversity of Michigan
- 2012$500K Cumulative Funding
- 2014$1M Cumulative Funding
- 2015R01 Grant Holder
- 2017$2M Cumulative Funding
- 2020Entered Top 50% NationallyRanked #3249
- 2020Entered Top 25% NationallyRanked #3249
- 2021$5M Cumulative Funding